Heinrich Taegtmeyer is a Cardiology physician. OpenAlex indexes 531 publications with 38,085 citations (h-index 83); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6410 Fannin St
600
Houston, TX 770303000
Telephone
832-325-7211Provider last certified this registry record 5 Dec 2023.
Clinical trials
- Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery
Sponsor: The University of Texas Health Science Center, Houston
- Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery
Sponsor: The University of Texas Health Science Center, Houston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
63.6%Statin24.2%Atorvastatin Calcium100%Part D<11 patientsAngiotensin receptor blocker (ARB)21.2%Losartan Potassium100%Part D<11 patients+ 1 more class in this area
Blood & clotting
18.2%P2Y12 inhibitor18.2%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
18.2%Biguanide (metformin)18.2%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 1985–2021 per NIH RePORTER. The latest:
- Axes of Oncometabolism in the Heart
University of Texas Hlth Sci Ctr Houston
FY2021$385,000R01HL061483 - Axes of Oncometabolism in the Heart
University of Texas Hlth Sci Ctr Houston
FY2020$385,000R01HL061483 - Axes of Oncometabolism in the Heart
University of Texas Hlth Sci Ctr Houston
FY2019$385,000R01HL061483
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”